Martin Reck, Konstantinos Ferentinos, Markus Joerger, Manuel Cobo, Benjamin Thiele, Manolo D'Arcangelo, Miguel F. Sanmamed, Mariam Alexander, Aakash Desai, Jhanelle E. Gray, Roy S. Herbst, Jorge J. Nieva, Rajwanth Veluswamy, Kathrin Klar, Marlene Fox, Vanja Radulovic, Lena Lemke, Eugen Leo, Sujata Rao, Felix Sebastian Lichtenegger. "Phase 2b randomized, blinded, placebo-controlled trial to investigate the efficacy and safety of visugromab added to pembrolizumab, pemetrexed, and carboplatin in first-line metastatic non-squamous NSCLC: GDFATHER-NSCLC-01.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8665